Effect of Niacin in the Lipoprotein (a) Concentration
Phase 4
Completed
- Conditions
- Hypercholesterolemia
- Interventions
- Drug: Niacin/Laropiprant
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- Instituto Aragones de Ciencias de la Salud
- Target Recruit Count
- 90
- Registration Number
- NCT01321034
- Locations
- 🇪🇸
Hospital San Jorge, Huesca, Spain
🇪🇸Hospital Royo Villanova, Zaragoza, Spain
🇪🇸Hospital Universitario Miguel Servet, Zaragoza, Spain
© Copyright 2025. All Rights Reserved by MedPath